Fluorescence diagnosis of lymph node metastasis of lung cancer in a mouse model

Oncology Reports

Volumn 22, Issue 1, 2009, Pages 17-21

  Takizawa, Hiromitsu ^a   Kondo, Kazuya ^b   Toba, Hiroaki ^a   Kenzaki, Koichiro ^a   Sakiyama, Shoji ^a   Tangoku, Akira ^a  

^a Institute of Health Biosciences   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Lung cancer; Lymph nodes

Indexed keywords

AMINOLEVULINIC ACID; FLUORESCENT DYE; MONO LEVO ASPARTYL CHLORINE E6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADMINISTRATION, ORAL; AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEASIBILITY STUDIES; FLUORESCENCE; HUMANS; INJECTIONS, INTRAPERITONEAL; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, SCID; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 68249151194     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000400     Document Type: Article

References (25)

1. Douillard JY, Rosell R, De Lena M, et al: Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer [Adjuvant Navelbine International Trialist Association (ANITA)]: a randomized controlled trial. Lancet Oncol 7: 719-727, 2006.
2. Robinson LA, Ruckdeschel JC, Wagner H Jr and Stevens CW; American College of Chest Physicians: Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 243-265, 2007.
3. Shim SS, Lee KS, Kim BT, et al: Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236: 1011-1019, 2005.
4. Lee BE, von Haag D, Lown T, Lau D, Calhoun R and Follette D: Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. J Thorac Cardiovasc Surg 133: 746-752, 2007.
5. Scott WJ, Howington J, Feigenberg S, Movsas B and Pisters K; American College of Chest Physicians: Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 234-242, 2007.
6. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K and Tsubota N: Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 132: 769-775, 2006.
7. Okumura M, Goto M, Ideguchi K, et al: Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. Lung Cancer 58: 231-237, 2007.
8. Denzinger S, Burger M, Walter B, et al: Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 69: 675-679, 2007.
9. Usuda J, Tsutsui H, Honda H, et al: Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer 58: 317-323, 2007.
10. Frimberger D, Linke R, Meissner H, et al: Fluorescence diagnosis: a novel method to guide radical inguinal lymph node dissection in penile cancer. World J Urol 22: 150-154, 2004.
11. Hillemanns P, Reiff J, Stepp H and Soergel P: Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report. Lasers Med Sci 22: 131-135, 2007.
12. Frei KA, Bonel HM, Frick H, Walt H and Steiner RA: Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. Br J Cancer 90: 805-809, 2004.
13. Ishikura H, Kondo K, Miyoshi T, Kinoshita H, Hirose T and Monden Y: Artificial lymphogenous metastatic model using orthotopic implantation of human lung cancer. Ann Thorac Surg 69: 1691-1695, 2000.
14. Izbicki JR, Passlick B, Pantel K, et al: Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 227: 138-144, 1998.
15. Sugi K, Nawata K, Fujita N, et al: Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 22: 290-294, 1998.
16. Wu Y, Huang ZF, Wang SY, Yang XN and Ou W: A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36: 1-6, 2002.
17. Allen MS, Darling GE, Pechet TT, et al; ACOSOG Z0030 Study Group: Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81: 1013-1019, 2006.
18. Bollen EC, van Duin CJ, Theunissen PH, vt Hof-Grootenboer BE and Blijham GH: Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 55: 961-966, 1993.
19. Muraoka M, Akamine S, Oka T, et al: Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 32: 356-361, 2007.
20. Asamura H, Nakayama H, Kondo H, Tsuchiya R and Naruke T: Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 117: 1102-1111, 1999.
21. Sugi K, Kaneda Y, Sudoh M, Sakano H and Hamano K: Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer. J Thorac Cardiovasc Surg 126: 568-573, 2003.
22. Nomori H, Ikeda K, Mori T, et al: Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 133: 780-785, 2007.
23. Prosst RL, Winkler S, Boehm E and Gahlen J: Thoracoscopic fluorescence diagnosis (TFD) of pleural malignancies: experimental studies. Thorax 57: 1005-1009, 2002.
24. Peng Q, Warloe T, Berg K, et al: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79: 2282-2308, 1997.
25. Kato H, Furukawa K, Sato M, et al: Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42: 103-111, 2003.